Aurinia Pharmaceuticals Inc. (AUPH)
Market Closed
17 Jul, 20:00
$
15. 96
+0.02
+0.1255%
$
2.06B Market Cap
- P/E Ratio
- Div Yield
788,900 Volume
-0.52 Eps
$ 15.94
Previous Close 
Want to track AUPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | 0.15 | 1.53 |
| | | 0.16 | - |
| | | 0.14 | 0.16 |
| | | - | - |
| | | - | - |
| | | 0.01 | - |
| | | 0.01 | 0.01 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.11 |
| | | - | - |
| | | - | - |
| | | - | - |
AUPH Earnings Reports FAQ
What is the earnings per share (EPS) for AUPH?
The current EPS is -0.52.
What is the company's earnings growth rate?
Over the past 12 years, the earnings growth rate has been approximately 26.71%, reflecting the AUPH's performance and NASDAQ (NMS) market conditions.
When is the next earnings release date?
Aurinia Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Aurinia Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for AUPH at this time, as Aurinia Pharmaceuticals Inc has no recent EPS data to calculate it.
